Reviewing trials with P2Y12 blocker (mono)therapy after ACS

5' education - June 29, 2021 - Prof. Freek Verheugt, MD, PhD - Amsterdam, The Netherlands

Educational information

This video was recorded in response to a recent publication in Neth Heart J by Verheugt and colleagues.

Faculty

Prof. Verheugt - cardioloog in Amsterdam, The Netherlands.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Find this article online at Neth Heart J

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.